Alan Eih Chih Thong, MD
Urology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 18
- 4 carriers
- Offices
- 2
Offices
2 locations · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
18 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Thong’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
18 of 18 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A109039 · Current
Licensed to practise in California · since 2009 · expires 2027-04-30 · University of Chicago, Pritzker School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$175,183
Medicare paid this office $175,183 for 605 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Surgical removal of prostate and surrounding lymph nodes using an endoscope | 17 | $18,059 | $1,062 |
| New patient visit (45+ min) | 128 | $16,228 | $127 |
| Long return visit (40+ min) | 92 | $16,191 | $164 |
| Partial removal of kidney using an endoscope | 12 | $15,892 | $1,324 |
| New patient visit (60+ min) | 67 | $11,174 | $167 |
See all 21 services
| Surgical removal of prostate and surrounding lymph nodes using an endoscope | 17 | $18,059 | $1,062 |
| New patient visit (45+ min) | 128 | $16,228 | $127 |
| Long return visit (40+ min) | 92 | $16,191 | $164 |
| Partial removal of kidney using an endoscope | 12 | $15,892 | $1,324 |
| New patient visit (60+ min) | 67 | $11,174 | $167 |
| Biopsy of prostate gland | 100 | $10,551 | $106 |
| Return visit (30+ min) | 91 | $10,158 | $103 |
| Diagnostic exam of bladder and urethra using an endoscope | 79 | $8,231 | $62 |
| New patient visit (45+ min) | 62 | $5,982 | $96 |
| Destruction and/or removal of large growth of bladder using an endoscope | 13 | $5,828 | $343 |
| Removal of lymph nodes of both sides of pelvis using an endoscope | 17 | $5,058 | $298 |
| Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | 11 | $3,180 | $245 |
| New patient visit (60+ min) | 21 | $3,043 | $145 |
| Biopsy of prostate gland | 26 | $2,875 | $111 |
| Return visit (30+ min) | 27 | $2,285 | $79 |
| Diagnostic exam of bladder and urethra using an endoscope | 27 | $2,238 | $62 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 105 | $1,735 | $15 |
| Ultrasound scan of pelvic region through rectum | 38 | $1,029 | $27 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 25 | $694 | $28 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 34 | $479 | $14 |
| Ultrasonic guidance for needle placement | 15 | $291 | $19 |
Procedures Medicare counted
| Prostate resection | 14 | More than 67% of doctors who do this |
Who their Medicare patients are
605 Original Medicare patients in 2024. Average age 74 · Under 65 4% · 85 and older 10% · Women 18% · Also on Medicaid 18% · Health risk score 1.41. Above the middle of the specialty; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 70% · Cancer 55% · Coronary heart disease 31% · Diabetes 30% · Chronic kidney disease 28% · Atrial fibrillation 20% · Heart failure 15% · Depression 15% · COPD 12% · Stroke 8% · Dementia 5%.
The office billed $1,756,609, Medicare allowed $232,650 and paid $175,183; for 1,206 services of 41 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 605 | 1,206 | 74 | 1.41 | $1,756,609 | $175,183 |
| 2023 | 610 | 1,075 | 75 | 1.33 | $1,633,336 | $173,878 |
| 2022 | 672 | 1,201 | 74 | 1.31 | $2,029,547 | $174,311 |
| 2021 | 563 | 1,185 | 74 | 1.34 | $1,803,350 | $174,959 |
| 2020 | 424 | 918 | 72 | 1.75 | $1,347,188 | $132,853 |
| 2019 | 542 | 1,069 | 73 | 1.40 | $1,168,706 | $157,939 |
| 2018 | 405 | 1,028 | 73 | 1.47 | $1,022,058 | $141,269 |
| 2017 | 272 | 629 | 72 | 1.23 | $629,908 | $85,846 |
| 2016 | 52 | 85 | 73 | 2.05 | $108,841 | $12,556 |
| 2015 | 30 | 32 | 72 | 1.67 | $9,840 | $1,510 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| New patient visit (45+ min) | 171 | $18,016 | $105 |
| Removal of kidney and lymph nodes using an endoscope | 13 | $14,693 | $1,130 |
| Long return visit (40+ min) | 86 | $12,333 | $128 |
| Diagnostic exam of bladder and urethra using an endoscope | 90 | $11,401 | $88 |
| New patient visit (60+ min) | 67 | $9,129 | $136 |
| New patient visit (45+ min) | 74 | $8,569 | $116 |
| Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | 29 | $8,505 | $250 |
| Biopsy of prostate gland | 67 | $7,237 | $108 |
| Return visit (30+ min) | 72 | $5,794 | $77 |
| New patient visit (60+ min) | 24 | $3,817 | $159 |
| Diagnostic exam of bladder and urethra using an endoscope | 24 | $2,062 | $67 |
| Long return visit (40+ min) | 14 | $1,862 | $133 |
| Ultrasonic guidance for needle placement | 55 | $1,397 | $25 |
| Ultrasound scan of pelvic region through rectum | 21 | $631 | $30 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 18 | $565 | $31 |
| Telehealth originating site facility fee | 11 | $247 | $22 |
2022: 20 services
| New patient visit (45+ min) | 208 | $23,534 | $113 |
| Surgical removal of prostate and surrounding lymph nodes using an endoscope | 11 | $14,424 | $1,311 |
| New patient visit (60+ min) | 81 | $13,380 | $165 |
| Long return visit (40+ min) | 95 | $12,833 | $130 |
| Return visit (30+ min) | 120 | $10,287 | $78 |
| Diagnostic exam of bladder and urethra using an endoscope | 83 | $9,509 | $93 |
| Biopsy of prostate gland | 71 | $7,439 | $105 |
| Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | 22 | $7,028 | $251 |
| New patient visit (45+ min) | 44 | $4,599 | $105 |
| Removal of lymph nodes of both sides of pelvis using an endoscope | 12 | $3,647 | $304 |
| Insertion of stent in ureter using an endoscope | 20 | $2,946 | $123 |
| New patient visit (60+ min) | 21 | $2,374 | $113 |
| Diagnostic exam of bladder and urethra using an endoscope | 27 | $2,308 | $70 |
| Return visit (30+ min) | 27 | $2,274 | $78 |
| Biopsy of prostate gland | 12 | $1,639 | $137 |
| Ultrasonic guidance for needle placement | 62 | $1,566 | $25 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 25 | $730 | $29 |
| Ultrasound scan of pelvic region through rectum | 29 | $703 | $24 |
| Telehealth originating site facility fee | 25 | $462 | $18 |
| Imaging of urinary tract following injection of a contrast agent | 11 | $319 | $23 |
2021: 17 services
| New patient visit (45+ min) | 166 | $19,301 | $116 |
| Return visit (30+ min) | 165 | $18,896 | $83 |
| Long return visit (40+ min) | 92 | $14,146 | $132 |
| Diagnostic exam of bladder and urethra using an endoscope | 72 | $9,207 | $101 |
| New patient visit (60+ min) | 50 | $8,339 | $167 |
| Biopsy of prostate gland | 65 | $7,028 | $106 |
| Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | 14 | $4,337 | $255 |
| New patient visit (45+ min) | 23 | $2,789 | $121 |
| Insertion of stent in ureter using an endoscope | 13 | $2,359 | $157 |
| Return visit (30+ min) | 25 | $2,293 | $88 |
| Ultrasound scan of pelvic region through rectum | 65 | $1,847 | $28 |
| Long return visit (40+ min) | 13 | $1,794 | $138 |
| Ultrasonic guidance for needle placement | 64 | $1,777 | $27 |
| Diagnostic exam of bladder and urethra using an endoscope | 16 | $1,404 | $70 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 23 | $738 | $32 |
| Imaging of urinary tract following injection of a contrast agent | 13 | $372 | $23 |
| Telehealth originating site facility fee | 15 | $340 | $21 |
2020: 16 services
| Surgical removal of prostate and surrounding lymph nodes using an endoscope | 15 | $19,661 | $1,311 |
| Return visit (30+ min) | 139 | $10,848 | $67 |
| New patient visit (45+ min) | 92 | $9,527 | $104 |
| Biopsy of prostate gland | 70 | $8,409 | $120 |
| Long return visit (40+ min) | 64 | $6,946 | $101 |
| Diagnostic exam of bladder and urethra using an endoscope | 53 | $6,763 | $88 |
| Removal of lymph nodes of both sides of pelvis using an endoscope | 15 | $4,686 | $312 |
| New patient visit (60+ min) | 24 | $3,391 | $141 |
| New patient visit (45+ min) | 22 | $2,521 | $115 |
| Insertion of stent in ureter using an endoscope | 11 | $2,246 | $160 |
| Ultrasound scan of pelvic region through rectum | 71 | $2,223 | $31 |
| Ultrasonic guidance for needle placement | 71 | $2,097 | $30 |
| Complicated removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 15 | $1,990 | $133 |
| Long return visit (40+ min) | 16 | $1,568 | $98 |
| Return visit (30+ min) | 18 | $1,113 | $62 |
| Telehealth originating site facility fee | 23 | $490 | $21 |
2019: 14 services
| Surgical removal of prostate and surrounding lymph nodes using an endoscope | 16 | $21,309 | $1,332 |
| Return visit (30+ min) | 190 | $14,426 | $65 |
| New patient visit (45+ min) | 131 | $14,020 | $107 |
| Diagnostic exam of bladder and urethra using an endoscope | 84 | $10,547 | $86 |
| New patient visit (60+ min) | 69 | $9,462 | $137 |
| Biopsy of prostate gland | 63 | $6,672 | $106 |
| Removal of lymph nodes of both sides of pelvis using an endoscope | 16 | $4,749 | $297 |
| Long return visit (40+ min) | 35 | $3,624 | $95 |
| New patient visit (45+ min) | 25 | $2,799 | $112 |
| Insertion of stent in ureter using an endoscope | 15 | $2,489 | $131 |
| New patient visit (60+ min) | 17 | $2,366 | $139 |
| Ultrasonic guidance for needle placement | 63 | $1,813 | $29 |
| Ultrasound scan of pelvic region through rectum | 63 | $1,780 | $28 |
| Electronic assessment of bladder emptying | 11 | $69 | $6 |
2018: 11 services
| Return visit (30+ min) | 161 | $14,594 | $69 |
| New patient visit (60+ min) | 91 | $13,243 | $146 |
| New patient visit (45+ min) | 103 | $11,545 | $112 |
| Diagnostic exam of bladder and urethra using an endoscope | 76 | $8,125 | $77 |
| Long return visit (40+ min) | 57 | $6,034 | $91 |
| Biopsy of prostate gland | 54 | $5,690 | $105 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 15 | $2,312 | $144 |
| Ultrasound scan of pelvic region through rectum | 54 | $1,544 | $29 |
| Ultrasonic guidance for needle placement | 54 | $1,530 | $28 |
| Short return visit (20+ min) | 28 | $1,224 | $44 |
| Electronic assessment of bladder emptying | 29 | $216 | $7 |
2017: 10 services
| New patient visit (60+ min) | 71 | $9,258 | $130 |
| New patient visit (45+ min) | 69 | $7,945 | $115 |
| Biopsy of prostate gland | 62 | $6,703 | $108 |
| Diagnostic exam of bladder and urethra using an endoscope | 44 | $4,908 | $98 |
| Long return visit (40+ min) | 41 | $4,778 | $100 |
| Return visit (30+ min) | 44 | $3,508 | $73 |
| Ultrasound scan of pelvic region through rectum | 61 | $1,742 | $29 |
| Ultrasonic guidance for needle placement | 60 | $1,714 | $29 |
| New patient visit (30+ min) | 15 | $1,097 | $73 |
| Short return visit (20+ min) | 17 | $1,036 | $49 |
2016: 1 service
| New patient visit (60+ min) | 15 | $2,116 | $141 |
2015: 1 service
| Short return visit (20+ min) | 22 | $988 | $45 |
Drugs they prescribed that Part D paid
$12,660
Pharmacies billed $12,660 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
229 generic and fewer than 11 brand-name prescriptions · $12,660 in drug cost · 11 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Alfuzosin Hcl Er | 65 | $1,538 | $24 |
| Tamsulosin | 52 | $988 | $19 |
| Finasteride | 54 | $604 | $11 |
| Doxazosin Mesylate | 12 | $64 | $5 |
| Atorvastatin | 12 | $8 | $1 |
Year by year
| 2024 | 235 | 72 | None | None | $12,660 |
| 2023 | 335 | 112 | None | None | $8,519 |
| 2022 | 409 | 136 | None | None | $9,459 |
| 2021 | 512 | 155 | 4% (19) | None | $13,341 |
| 2020 | 401 | 131 | 4% (14) | None | $9,010 |
| 2019 | 426 | 149 | 8% (32) | None | $11,007 |
| 2018 | 429 | 129 | 11% (46) | None | $11,698 |
| 2017 | 138 | 69 | None | None | $4,494 |
| 2016 | 93 | 48 | 26% (24) | None | $2,977 |
| 2015 | 18 | 15 | None | 0% | $97 |
| 2013 | 38 | 25 | 45% (17) | None | $699 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Alfuzosin Hcl Er | 114 | $3,005 | $26 |
| Tamsulosin | 65 | $1,729 | $27 |
| Finasteride | 84 | $1,225 | $15 |
| Ciprofloxacin | 11 | $114 | $10 |
| Doxazosin Mesylate | 12 | $57 | $5 |
2022: 6 drugs
| Tamsulosin | 129 | $2,455 | $19 |
| Finasteride | 120 | $2,196 | $18 |
| Alfuzosin Hcl Er | 72 | $1,936 | $27 |
| Dutasteride | 13 | $1,477 | $114 |
| Amoxicillin-Clavulanate Potass | 13 | $173 | $13 |
| Doxazosin Mesylate | 12 | $96 | $8 |
2021: 7 drugs
| Tamsulosin | 173 | $3,366 | $19 |
| Finasteride | 135 | $2,825 | $21 |
| Alfuzosin Hcl Er | 56 | $1,838 | $33 |
| Oxybutynin Chloride Er | 35 | $1,121 | $32 |
| Amoxicillin-Clavulanate Potass | 11 | $165 | $15 |
| Doxazosin Mesylate | 12 | $79 | $7 |
| Hydrocodone-Acetaminophen | 18 | $62 | $3 |
2020: 6 drugs
| Finasteride | 128 | $2,716 | $21 |
| Tamsulosin | 134 | $2,477 | $18 |
| Alfuzosin Hcl Er | 34 | $1,315 | $39 |
| Oxybutynin Chloride Er | 22 | $1,159 | $53 |
| Doxazosin Mesylate | 12 | $206 | $17 |
| Hydrocodone-Acetaminophen | 13 | $56 | $4 |
2019: 7 drugs
| Tamsulosin | 149 | $3,915 | $26 |
| Finasteride | 106 | $2,574 | $24 |
| Oxybutynin Chloride Er | 24 | $915 | $38 |
| Dutasteride | 11 | $889 | $81 |
| Alfuzosin Hcl Er | 23 | $711 | $31 |
| Amoxicillin-Clavulanate Potass | 11 | $131 | $12 |
| Hydrocodone-Acetaminophen | 30 | $115 | $4 |
2018: 6 drugs
| Tamsulosin | 113 | $2,850 | $25 |
| Finasteride | 103 | $2,614 | $25 |
| Oxybutynin Chloride Er | 47 | $1,386 | $29 |
| Dutasteride | 11 | $706 | $64 |
| Hydrocodone-Acetaminophen | 38 | $184 | $5 |
| Ciprofloxacin | 34 | $117 | $3 |
2017: 3 drugs
| Tamsulosin | 43 | $960 | $22 |
| Oxybutynin Chloride Er | 15 | $527 | $35 |
| Finasteride | 24 | $380 | $16 |
2016: 4 drugs
| Tamsulosin | 14 | $427 | $30 |
| Hydrocodone-Acetaminophen | 22 | $150 | $7 |
| Finasteride | 13 | $88 | $7 |
| Ciprofloxacin | 18 | $50 | $3 |
2013: 1 drug
| Hydrocodone-Acetaminophen | 16 | $133 | $8 |
Money from drug and device companies
$7,442 in 2025
| 2025 | 1 | 14 | $1,500 | $7,442 |
| 2024 | 4 | 24 | None | $6,223 |
| 2023 | 3 | 8 | $200 | $620 |
| 2022 | 3 | 16 | None | $7,575 |
| 2021 | 1 | 1 | None | $224 |
| 2020 | 1 | 5 | None | $477 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Intuitive Surgical | Da Vinci Surgical System | $7,442 | 14 payments
|
See all 14 published payments
| Intuitive Surgical | Meals · 2025-12-30 | Da Vinci Surgical System | $119 |
| Intuitive Surgical | Paid to speak or teach · 2025-12-17 | Da Vinci Surgical System | $500 |
| Intuitive Surgical | Paid to speak or teach · 2025-12-17 | Da Vinci Surgical System | $500 |
| Intuitive Surgical | Paid to speak or teach · 2025-11-19 | Da Vinci Surgical System | $500 |
| Intuitive Surgical | Meals · 2025-07-29 | Da Vinci Surgical System | $65 |
| Intuitive Surgical | Travel · 2025-06-21 | Da Vinci Surgical System | $19 |
| Intuitive Surgical | Education · 2025-05-14 | Da Vinci Surgical System | $4,000 |
| Intuitive Surgical | Travel · 2025-05-13 | Da Vinci Surgical System | $182 |
| Intuitive Surgical | Travel · 2025-05-08 | Da Vinci Surgical System | $182 |
| Intuitive Surgical | Meals · 2025-05-05 | Da Vinci Surgical System | $31 |
| Intuitive Surgical | Travel · 2025-04-22 | Da Vinci Surgical System | $6 |
| Intuitive Surgical | Meals · 2025-04-11 | Da Vinci Surgical System | $391 |
| Intuitive Surgical | Travel · 2025-02-12 | Da Vinci Surgical System | $37 |
| Intuitive Surgical | Travel · 2025-02-12 | Da Vinci Surgical System | $910 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $6,223
| Edap Technomed | None | $5,088 | 18 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $878 | 3 payments
|
| Urogen Pharma | Jelmyto | $130 | 2 payments
|
| Ethicon US | Echelon Flex | $126 | 1 payment
|
2023: $620
| Intuitive Surgical | Da Vinci Sp | $243 | 4 payments
|
| UroGen Pharma | Jelmyto | $229 | 3 payments
|
| Edap Technomed | None | $148 | 1 payment
|
2022: $7,575
| Intuitive Surgical | Da Vinci Sp | $6,795 | 10 payments
|
| UroGen Pharma | Jelmyto | $680 | 5 payments
|
| Dornier MedTech America | Dornier Medtech | $100 | 1 payment
|
2021: $224
| Dornier MedTech America | Consumables & Accessories | $224 | 1 payment
|
2020: $477
| Intuitive Surgical | Da Vinci Surgical System | $477 | 5 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1689835738
- Licence
- CA A109039, NY 274598California A109039: Current · expires 2027-04-30
- Trained
- University of Chicago, Pritzker School of Medicine, 2008
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Urology (208800000X); Surgery (208600000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2008-06-21
- NPI last updated
- 2024-03-13
- NPI record certified
- 2024-03-13
This is when the NPI record was last certified, not a medical board exam.